Drive your R&D success with Cortellis Drug Discovery Intelligence

Integrated biology, chemistry & pharmacology data in one platform

Accelerate drug development with the most comprehensive scientific pipeline database.

  • Gain competitive insights into drug status globally.
  • Make faster go/no-go decisions to advance promising drugs efficiently.
  • Leverage contextual insights backed by best-in-class data and expertise.

Comprehensive data at your fingertips:

  • 709K+ drugs & biologics
  • 222K+ experimental models
  • 49K+ genes & targets
  • 47K+ biomarkers

…and more.

north_east

Request more information

Built by scientists for scientists

Cortellis Drug Discovery Intelligence unifies drug pipeline insights with data on experimental models, biomarkers, and gene studies. Curated by PhD and MD experts and enhanced with AI, it offers 35+ years of trusted data on drugs, targets, pharmacology, patents, and safety.

Identify, validate & prioritize targets

Make confident go/no-go decisions with our target-disease scoring heatmap and quickly access detailed insights on target roles, lifecycle phases and key references.

Benchmark & improve drug candidates

Compare similar drugs, assess competitors, and benchmark experimental performance while using historical research to design smarter, stronger experiments.

Explore metabolic pathways

Assess in vitro and in vivo drug activity, uncover off-target effects, and identify the most suitable assays to test your molecules’ efficacy.

Speed up compound synthesis

Benchmark candidates by pharmacology and PK, explore new synthesis routes, and optimize lead compounds using past research or novel chemical series insights.

Want to learn more?

Increase the success of your preclinical drug discovery programs.

Book a free demo. north_east

What our customers says

See how professionals across chemistry, biology, and drug development use Cortellis to gain competitive insight and advance programs efficiently.

“By reducing the time and money spent on manually compiling and tracking all drug development research, we have freed up resources to focus on more value-added work.”

Stefania Meola Head of Medicinal Chemistry, Italfarmaco

“The research solutions from Clarivate encompass all aspects of data and analytics that give us a commercial advantage.”

Richard Allman CEO at Cleo

“For over 10 years, the Cortellis Drug Discovery Intelligence database has proven instrumental in my efforts for understanding competitive landscapes, monitoring current target developments, and exploring disease profiles."

William C. Stafford Fulgurite AB

chevron_left
chevron_right

FAQs

Cortellis Drug Discovery Intelligence delivers unmatched depth and breadth of expert-curated data, bringing biological, chemical, and pharmacological insights together in one platform. Quickly connect the dots between disease, targets, drugs, and biomarkers, and access validated details on patents, mechanisms of action, experimental models, and safety profiles to accelerate confident go / no go decisions.

Yes. Expert-curated insights from Cortellis Drug Discovery Intelligence are cited in from leading universities and pharmaceutical R&D teams. Dozens of manuscripts have used Cortellis Drug Discovery Intelligence data to support discoveries in fields such as oncology, immunology, and rare diseases—helping researchers turn hypotheses into evidence.

Cortellis Drug Discovery Intelligence provides you with an integrated source of biological, chemical, and pharmacological data from disparate sources into a single drug discovery platform. Our team of scientific experts select and curate data from the following sources:

  • 1500+ scientific journals
  • 160+ international conferences
  • 7 main patent offices
  • Regulatory agencies (FDA, EMA, PMDA & TGA)
  • ClinicalTrials.gov
  • Pharma & biotech company web pages

Yes, you can leverage bulk data from this drug discovery database as a data feed or API to populate internal data and analytics solutions.

Request more information

Request more information